BioCentury
ARTICLE | Company News

Bioglan, Quintiles Transnational Corp. deal

March 25, 2002 8:00 AM UTC

QTRN acquired most of the assets of Bioglan Pharma Inc., the U.S. subsidiary of BGP, for $26.7 million in cash. Included in the deal were North American marketing rights to certain dermatology product...